Show simple item record

dc.contributor.advisorTrinkaus-Randall, Vickery E.en_US
dc.contributor.advisorOffner, Gwynneth D.en_US
dc.contributor.authorGoicoechea, Steven C.en_US
dc.date.accessioned2018-09-07T17:14:56Z
dc.date.available2018-09-07T17:14:56Z
dc.date.issued2018
dc.identifier.urihttps://hdl.handle.net/2144/31232
dc.description.abstractHepatitis C is a public health crisis in both developing and developed countries. Direct acting antiviral therapies have revolutionized the fight against Hepatitis C, making the worldwide eradication of the disease feasible. However, screening and access to care for vulnerable patients – especially for patients experiencing homelessness – are lacking. Homelessness exacerbates the effects of Hepatitis C, leading to poor health outcomes for individual patients and high costs for health providers and taxpayers. One potential solution is investing in affordable housing and the housing first model that provide the stability needed to address both acute and chronic health conditions, including Hepatitis C. Partnerships between patients and providers facilitated by supportive housing can benefit individual outcomes and decrease the financial and social costs to communities.en_US
dc.language.isoen_US
dc.subjectMedicineen_US
dc.subjectDAAen_US
dc.subjectDirect acting antiviralen_US
dc.subjectHCVen_US
dc.subjectHepatitis Cen_US
dc.subjectHomelessen_US
dc.subjectHomelessnessen_US
dc.titleHomelessness and Hepatitis C: risk factors and treatmenten_US
dc.typeThesis/Dissertationen_US
dc.date.updated2018-07-12T22:02:09Z
etd.degree.nameMaster of Scienceen_US
etd.degree.levelmastersen_US
etd.degree.disciplineMedical Sciencesen_US
etd.degree.grantorBoston Universityen_US


This item appears in the following Collection(s)

Show simple item record